Incremental Cost-Effectiveness of Surgical vs. Percutaneous Treatment of Patent Ductus Arteriosus with the Amplatzer™ Duct Occluder in Children: A Systematic Review

Conclusions Percutaneous occlusion was associated with less morbidity and shorter hospital stay with similar incremental effectiveness when compared to the surgical treatment. With the direct costs used in this study and considering that the entire population with PDA is treated with the ADO, percutaneous occlusion was less cost-effective. However, a slight reduction in the costs of the percutaneous kit would result in a aceptable ICER threshold for possible incorporation by the SUS. DESCRIPTORS Ductus arteriosus, patent, Heart defects, congenital, Surgery, Prostheses and implants, Cost-benefit analysis.
Source: Revista Brasileira de Cardiologia Invasiva - Category: Cardiology Source Type: research